Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001058:Apomorphine / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009714:Nucleus Accumbens / Q000187:drug effects*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D012686:Septal Nuclei / Q000187:drug effects*
D014150:Antipsychotic Agents; D006892:Hydroxydopamines; D008781:Methyltyrosines; D011955:Receptors, Drug; D001058:Apomorphine; D003913:Dextroamphetamine